Atrial fibrillation (AF) ablation is an established therapy for symptomatic AF. As a non-pharmacological therapy for AF that in ∼60–70% of patients provides a durable reduction in AF recurrence risk, there exists hope that AF-related co-morbidities may be reduced. Large observational trials have shown that AF ablation is associated with lower rates of stroke, dementia, heart failure, and mortality.1,2
Eur Heart J. 31 January, 2019. Epub ahead of print.